黑料网

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Clin Pharmacol Biopharm,

Biopharmaceuticals' Immunogenicity

Laurie Corkins*
Department of Pharmacology, Tritiny College of Dublin, United Kingdom
*Corresponding Author : Laurie Corkins, Department of Pharmacology, Tritiny College of Dublin, United Kingdom, Email: lauriecorkins@gublin.ac.uk

Received Date: Apr 01, 2024 / Accepted Date: Apr 30, 2024 / Published Date: Apr 30, 2024

Abstract

Biopharmaceuticals have revolutionized healthcare by offering targeted and efficacious treatment options for a myriad of diseases. However, concerns about their high costs and affordability have sparked discussions about their cost-effectiveness. This abstract provides a succinct overview of the complex interplay between innovation and affordability in the realm of biopharmaceuticals, examining the factors influencing pricing, economic impact, and strategies for achieving sustainable healthcare delivery.

Citation: Laurie C (2024) Biopharmaceuticals' Immunogenicity. Clin PharmacolBiopharm, 13: 444.

Copyright: © 2024 Laurie C. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top